# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-25-010891
Filing Date
2025-04-03
Accepted
2025-04-03 16:00:36
Documents
19
Period of Report
2025-05-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM PRE 14A | sava20250323_pre14a.htm iXBRL | PRE 14A | 762210
6 |  | logocolor01.jpg | GRAPHIC | 17725
7 |  | pcxy01.jpg | GRAPHIC | 264893
8 |  | pcxy02.jpg | GRAPHIC | 350946
9 |  | smlogo.jpg | GRAPHIC | 13290
| Complete submission text file | 0001437749-25-010891.txt |  | 3160571

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | sava-20241231.xsd | EX-101.SCH | 4291
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | sava-20241231_def.xml | EX-101.DEF | 2075
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | sava-20241231_lab.xml | EX-101.LAB | 2461
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | sava-20241231_pre.xml | EX-101.PRE | 1282
21 | EXTRACTED XBRL INSTANCE DOCUMENT | sava20250323_pre14a_htm.xml | XML | 166095

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41905 | Film No.: 25809249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)